Osteoviva® contains the active substance ibandronic acid.
Osteoviva® belongs to a group of medicines called bisphosphonates. Osteoviva® can counteract bone loss by stopping further bone loss and increasing bone mass in most women who take it. Osteoviva® can help reduce the risk of bone fractures.
Osteoviva® is used to treat osteoporosis in postmenopausal women at increased risk of fractures.
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.Login